Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
OTC Markets OTCPK - Delayed Quote USD

Inventiva S.A. (IVEVF)

Compare
3.6400
0.0000
(0.00%)
At close: January 23 at 7:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
17,477
17,477
12,179
4,194
372
Operating Expense
120,142
120,142
69,036
55,368
26,918
Operating Income
-102,665
-102,665
-56,857
-51,174
-26,546
Net Non Operating Interest Income Expense
-4,233
-4,233
-364
-86
152
Other Income Expense
-2,920
-2,920
2,927
1,985
-7,224
Pretax Income
-109,818
-109,818
-54,294
-49,275
-33,618
Tax Provision
607
607
-20
364
--
Net Income Common Stockholders
-110,426
-110,426
-54,274
-49,635
-33,619
Diluted NI Available to Com Stockholders
-110,426
-110,426
-54,274
-49,635
-33,619
Basic EPS
-2.43
-2.43
-1.31
-1.27
-0.99
Diluted EPS
-2.43
-2.43
-1.31
-1.27
-0.99
Basic Average Shares
45,351.7990
45,351.7990
41,449.7320
39,168.1520
33,874.7510
Diluted Average Shares
45,351.7990
45,351.7990
41,449.7320
39,168.1520
33,874.7510
Total Operating Income as Reported
-102,709
-102,709
-57,110
-52,114
-29,718
Total Expenses
120,142
120,142
69,036
55,368
26,918
Net Income from Continuing & Discontinued Operation
-110,426
-110,426
-54,274
-49,635
-33,619
Normalized Income
-109,747.2500
-109,747.2500
-57,199.2438
-51,093.9750
-26,395
Interest Income
991
991
390
57
226
Interest Expense
5,178
5,178
707
138
66
Net Interest Income
-4,233
-4,233
-364
-86
152
EBIT
-104,640
-104,640
-53,587
-49,137
-33,552
EBITDA
-102,041
-102,041
-51,889
-48,961
-31,664
Reconciled Depreciation
2,599
2,599
1,698
-1,288
1,888
Net Income from Continuing Operation Net Minority Interest
-110,426
-110,426
-54,274
-49,635
-33,619
Total Unusual Items Excluding Goodwill
-905
-905
2,927
1,985
-7,224
Total Unusual Items
-905
-905
2,927
1,985
-7,224
Normalized EBITDA
-101,136
-101,136
-54,816
-50,946
-24,440
Tax Rate for Calcs
0.0003
0.0003
0
0.0003
--
Tax Effect of Unusual Items
-226.2500
-226.2500
1.7562
526.0250
--
12/31/2020 - 5/7/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0M4.DU Mersana Therapeutics Inc
0.5262
+0.15%
 
0M4.MU Mersana Therapeutics Inc
0.5268
+1.97%
 
ROVI.MC Laboratorios Farmaceuticos Rovi, S.A.
55.15
+0.64%
 
CARM Carisma Therapeutics, Inc.
0.4420
-1.82%
 
AEON AEON Biopharma, Inc.
0.0675
-43.89%
 
MRSN Mersana Therapeutics, Inc.
0.5566
+4.39%